MedPath

Fluorescence labeling using indocyanine green in the sentinel lymph node excision. Clinical evaluation of the Fluobeam system

Completed
Conditions
C43
Malignant melanoma of skin
Registration Number
DRKS00004619
Lead Sponsor
niversitätsklinikum Essen,Klinik für Dermatologie und Venerologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with a malignant melanoma at the trunk or extremities, stage Ib and II (AJCC 2009)

Exclusion Criteria

Age < 18 years, Indocyaningreen intolerance, iodine allergy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of sentinel positivity
Secondary Outcome Measures
NameTimeMethod
False negative rate, surgery duration, mean number of SNs excised per patient using both methods, Determine the costs of both methods<br><br>
© Copyright 2025. All Rights Reserved by MedPath